Skip to main content

Featured

Carney Tempers Expectations on U.S.-Canada Trade Talks

                                             Carney says U.S. tariff reprieve 'unlikely' to happen before CUSMA review talks. Canadian Prime Minister Mark Carney has downplayed the likelihood of a near-term trade deal between Canada and the United States, signaling that any progress will likely be folded into the upcoming review of the Canada-U.S.-Mexico Agreement (CUSMA) scheduled for 2026. Speaking at a press conference in Ottawa, Carney explained that efforts to secure sector-specific agreements—particularly in industries such as steel, aluminum, autos, and lumber—have stalled since U.S. President Donald Trump abruptly ended negotiations in October. The talks were derailed after Ontario aired a controversial anti-tariff advertisement featuring former President Ronald Reagan, which drew sharp criticism from Washington. Carney emphasized that while Canada...
Post a Comment
Read more

article

Labels

Trump’s Tariff Blitz: Pharmaceuticals and Chips in the Crosshairs

The Trump administration has launched investigations into imports of pharmaceuticals and semiconductors, citing national security concerns. These probes, initiated under Section 232 of the Trade Expansion Act of 1962, aim to impose tariffs to reduce reliance on foreign production. Pharmaceuticals and semiconductors, which are largely sourced from countries like India, China, and Taiwan, are seen as critical to U.S. security. While the administration argues that tariffs will boost domestic manufacturing, critics warn of potential shortages and increased costs for consumers. 

The move follows exemptions for smartphones and computers from steep reciprocal tariffs, signaling a strategic shift in trade policy. As markets react to these developments, the global economic landscape faces uncertainty. 



Labels:

Comments

Post a Comment